³ë¾È¡¤¹é³»Àå¼¾ÅÍ

¹®¾È°ú ÀÇ·áÁøÀº ü°èÀûÀÎ ½Ã½ºÅÛÀ¸·Î ÃÖ¼±ÀÇ Áø·á¸¦ Á¦°øÇÕ´Ï´Ù.

´ëÇ¥ÀüÈ­
031.251.1373

Áø·á½Ã°£ ¾È³»

  • Æò      ÀÏ
  • AM 9:00 ~ PM 6:00
  • Åä ¿ä ÀÏ
  • AM 9:00 ~ PM 4:00
  • °ø ÈÞ ÀÏ
  • AM 9:00 ~ PM 1:00
  • Á¡½É½Ã°£
  • PM 1:00 ~ PM 2:00
  • ÀÏ¿äÀÏ ÈÞÁø
¼¾ÅÍ ¼Ò°³
> ³ë¾È¡¤¹é³»Àå¼¾ÅÍ > ¼¾ÅÍ ¼Ò°³

Á¶°üÇõ ´ëÇ¥ ºÎ¿øÀå

ÀÇÇйڻç/¾È°úÀü¹®ÀÇ/ ¸Á¸·Àü¹®ÀÇ/ Çѱ¹¸Á¸·ÇÐȸÁ¤È¸¿ø

¡¤ ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ
¡¤ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¸Á¸·ÀüÀÓÀÇ
¡¤ ÀÇ·á¹ýÀÎ Çѱæ¾È°úº´¿ø ¸Á¸·¼¾ÅÍ °úÀå (°¡Å縯°üµ¿ÀÇ´ë±³¼ö)
¡¤ ¹Ì±¹ÀÇ»çÀÚ°Ý Ãëµæ (USMLE,New York State, United States)
¡¤ ¹Ì±¹ ´º¿å Ä÷³ºñ¾Æ Àǰú´ëÇÐ ¾È°ú¿¬¼ö(Columbia University Medical Center, Edward S. Harkness Eye Institute, New York)
¡¤ ¸¶¸£ÄûÁî ÈĽºÈÄ (Marquis Who¡¯s Who) - ¼¼°è3´ëÀθí»çÀü, ÀÇÇоȰúºÐ¾ßµîÀç
¡¤ û¿Í´ë Àǹ«½Ç ±ºÀǰü (¼öµµ¹æÀ§»ç·ÉºÎ)
¡¤ 2016 ´ëÇѾȰúÇÐȸ Çмú»ó/2017 ¾Æ½Ã¾ÆÅÂÆò¾ç¸Á¸·ÇÐȸ ¿ì¼ö¿¬±¸ÀÚ»ó (APVRS)

¼Ò¼ÓÇÐȸ

¡¤ Çѱ¹¸Á¸·ÇÐȸ º¸ÇèÀ§¿ø / ¼ö¿ø½ÃÀÇ»çȸ Àǹ«ÀÌ»ç
¡¤ ´ëÇѾȰúÇÐȸ / Çѱ¹Æ÷µµ¸·ÇÐȸ / Çѱ¹¸Á¸·ÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹¾È°úÇÐȸ(AAO) / ¹Ì±¹½Ã°úÇבּ¸È¸(ARVO) Á¤È¸¿ø
¡¤ ¹Ì±¹ Journal of Clinical & Medical Images ³í¹® ½É»çÀ§¿ø
¡¤ ¼ö¿ø½Ã ¾Æµ¿ÀÇ·áÁö¿ø»ç¾÷ ºÎÀ§¿øÀå

ÁÖ¿äÇÐȸ¹ßÇ¥

¡¤ 2014ARVO in Orlando / 2015 AAO in Las Vegas
¡¤ 2016 ARVO in Seattle / 2016 AAO in Chicago
¡¤ 2017 ASCRS in Los Angeles / 2017 APVRS in Kuala Lumpur

ÁÖ¿ä³í¹® : (SCI ³í¹® Á¦1ÀúÀÚ,Ã¥ÀÓÀúÀÚ¸¸ ±âÀç,Àü¼¼°è Top3 ¾È°ú³í¹® 10¿©Æí, ¸ñ·Ï÷ºÎ)

¡¤ ¸Á¸·³»Ãþ ºÒ±ÔÄ¢ Áö¼ö¸¦ ÀÌ¿ëÇÑ ¸Á¸·Àü¸·ÀÇ ¿¹ÈÄ ¿¹Ãø - ¹Ì±¹¾È°úÀú³Î(AJO) 2016
¡¤ ¸Á¸·µ¿¸ÆÆó¼â ȯÀÚÀÇ Ç÷Àü ¾ç»ó ºÐ¼® - ¹Ì±¹¾È°úÀú³Î(AJO) 2016
¡¤ ¸Á¸·ºÐÁöÁ¤¸ÆÆó¼â ȯÀÚÀÇ ³úÇ÷°ü ³ªÀÌ ºÐ¼® - ¹Ì±¹½Ã°úÇÐÇÐȸÀú³Î(IOVS) 201
¡¤ ¸Á¸·¹Ú¸® ȯÀÚÀÇ ¼ú ÈÄ ±¼Àý°ª º¯È­ - ¹Ì±¹¾È°úÀú³Î(AJO) 2014

ÃÖ±Ù SCI ³í¹® ¸ñ·Ï (Á¦ 1ÀúÀÚ, Ã¥ÀÓÀúÀÚ¸¸ ±âÀç)

1. Kim MS, Moon JH, Lee MW, Cho KH (2022), Analysis of postoperative intraocular pathologies in patients with mature cataracts. PLoS ONE 17(1): e0263352.

2. Cho KH, Park SJ, Cho JH, Woo SJ, Park KH. Inner-retinal Irregularity Index Predicts Postoperative Visual Prognosis in Idiopathic Epiretinal Membrane. Am J Ophthalmol. 2016 Aug;168:139-49

3. Cho KH, Ahn SJ, Jung C, Han MK, Park KH, Woo SJ. Ischemic Injury of the Papillomacular Bundle Is a Predictive Marker of Poor Vision in Eyes with Branch Retinal Artery Occlusion. Am J Ophthalmol. 2016 Feb;162:107-120

4. Cho KH, Park IW, Kwon SI. Changes in postoperative refractive outcomes following combined phacoemulsification and pars plana vitrectomy for rhegmatogenous retinal detachment. Am J Ophthalmol. 2014 Aug;158(2):251-256

5. Cho KH, Park SJ, Woo SJ, Park KH. Correlation between Inner-retinal changes and outer-retinal damage in patients with idiopathic epiretinal membrane. Retina 2017 Oct 23.

6. Cho KH, Ahn SJ, Jung C, Han MK, Park KH, Woo SJ. The characteristics of retinal emboli and its association with vascular reperfusion in retinal artery occlusion. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4589-98

7. Cho KH, Kim CK, Woo SJ, Park KH, Park SJ. Cerebral Small Vessel Disease in Branch Retinal Artery Occlusion. Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5818-5824.

8. Cho KH, Kim CK, Oh K, Oh SW, Park KH, Park SJ. Retinal Vein Occlusion as the Surrogate Marker for Premature Brain Aging in Young Patients. Invest Ophthalmol Vis Sci. 2017 May 1;58(6).

9. Cho KH, Kim J, Choi DG, Lee JY. Do the primary surgical option for basic-type exotropia cause differences in distance-near discrepancy of recurrent exotropia after surgery? PLoS One. 2019 Aug 19;14(8)

10. Cho KH, Kim HW, Choi DG, Lee JY. Type of the recurrent exotropia after bilateral rectus recession for intermittent exotropia. BMC Ophthalmol. 2016 Jul 8;16:97

11. Cho KH, Lee JY Correction of Hypertropia Coexisting with Intermittent Exotropia, J Korean Ophthalmol Soc 2014;55(12):1883-1889

12. Cho KH, Lee MJ A Case of Canaliculocele Treated with Punctoplasty and Marsupialization J Korean Ophthalmol Soc 2014;55(6):898-901

¹®Á¤ÈÞ ´ëÇ¥¿øÀå

ÀÇÇйڻç /¾È°úÀü¹®ÀÇ / ½Ã·Â±³Á¤,¼ºÇü¾È°ú Àü¹®ÀÇ

¡¤ ¹®¾È°ú ´ëÇ¥¿øÀå
¡¤ °æÈñ´ëÇб³ Àǰú´ëÇÐ ÀÇÇйڻç
¡¤ îñ)´ëÇѾȰúÇÐȸ ºÎȸÀå
¡¤ îñ)¼ö¿ø½ÃÀÇ»çȸ ȸÀå
¡¤ îñ)°æÈñÀÇ´ë ¾È°úÇб³½Çµ¿¹®È¸Àå
¡¤ îñ)µ¿¼ö¿øº´¿ø ¾È°ú°úÀå
¡¤ 1990³â ±¹³» ¶ó½Ä¼ö¼ú µµÀÔ 1¼¼´ë - ½Ã·Â±³Á¤¼ú Áýµµ ÃÑ6¸¸°Ç
¡¤ ¾Æ½Ã¾ÆÅÂÆò¾ç¾È°úÇÐȸ °ø·Î»ó ¼ö»ó

ÁÖ¿äÇØ¿Ü ¿¬¼ö ¹× ÇÐȸ¹ßÇ¥

¡¤ 1991 USA Anaheim ¹Ì±¹¾È°úÇÐȸ
¡¤ 1992 USA Sanfrancisco ¹Ì±¹¾È°úÇÐȸ
¡¤ 1994 USA Atlanta ¹Ì±¹¾È°úÇÐȸ
¡¤ 1995 Deutch Achen University ¿¬¼ö
¡¤ 1996 USA Seattle ¹Ì±¹±¼Àý¼ö¼úÇÐȸ
¡¤ 1997 USA Boston ¹Ì±¹±¼Àý¼ö¼úÇÐȸ
¡¤ 2002 Greece À¯·´±¼Àý¼ö¼úÇÐȸ
¡¤ 2007 USA SanDiego ¹Ì±¹±¼Àý¼ö¼úÇÐȸ
¡¤ 2009 USA Sanfrancisco ¹Ì±¹¾È°úÇÐȸ

¼Ò¼ÓÇÐȸ

¡¤ ´ëÇÑ ¾È°úÇÐȸ Á¤È¸¿ø
¡¤ ´ëÇÑ ¹é³»Àå ±¼Àý¼ö¼úÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹ ¾È°úÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹ ¹é³»Àå ±¼Àý¼ö¼úÇÐȸ Á¤È¸¿ø
¡¤ ¾Æ½Ã¾ÆÅÂÆò¾ç¸Á¸·ÇÐȸ ½É»çÀ§¿ø

±è¹Î¼® ¿øÀå

¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ / Çѱ¹¸Á¸·ÇÐȸ Á¤È¸¿ø

¡¤ ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ÀÓ»ó°­»ç
¡¤ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¸Á¸· ÀüÀÓÀÇ
¡¤ ¸ñÆ÷½ÃÀÇ·á¿ø ¾È°ú°úÀå
¡¤ ÀÎÁ¦´ëÇб³ »ó°è¹éº´¿ø ¾È°ú Àü°øÀÇ

¼Ò¼ÓÇÐȸ

¡¤ ´ëÇѾȰúÇÐȸ / Çѱ¹¸Á¸·ÇÐȸ Á¤È¸¿ø
¡¤ À¯·´¸Á¸·ÇÐȸ (EURETINA) / ¹Ì±¹½Ã°úÇבּ¸È¸ (ARVO) Á¤È¸¿ø

ÁÖ¿äÇÐȸȰµ¿

¡¤ 2014 EVER in France, Nice
¡¤ 2018 APVRS in Korea, Seoul
¡¤ 2019 ARVO in Canada, Vancouver
¡¤ 2019 EURETINA in France, Paris
¡¤ 2019 ´ëÇѾȰúÇÐȸ Ãß°èÇÐȸ ºñµð¿À, ±¸¿¬, Æ÷½ºÅÍ ¹ßÇ¥

ÁÖ¿ä³í¹®: (³í¹® 1ÀúÀÚ)

1.Kim MS, Moon JH, Lee MW, Cho KH(2022), Analysis of postoperative intraocular pathologies in patients with mature cataracts. PLoS ONE 17(1): e0263352.

2. Kim MS, Lee KM, Hwang JM, Yang HK, Woo SJ. Morphologic Features of Buried Optic Disc Drusen on En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography. American Journal of Ophthalmology. 2020 May;213:125-133.

3. Kim MS, Kim JS, Woo SJ. Toxic crystalline retinopathy due to overdose of intravitreal ganciclovir. JAMA Ophthalmol. 2019 Dec 1;137(12)

4. Kim MS, Jeong HY, Cho KH, Oh SW, Byun SJ, Woo SJ, Yang HK, Hwang JM, Park KH, Kim CK, Park SJ. Nonarteritic anterior ischemic optic neuropathy is associated with cerebral small vessel disease. PLoS One. 2019 Nov 14;14(11)

5. Kim MS, Park SJ, Park KH, Woo SJ. Different mechanistic association of myopia with rhegmatogenous retinal detachment between young and elderly patients. Biomed Res Int. 2019 Aug

6. Kim MS, Joo K, Seong MW, Kim MJ, Park KH, Park SS, Woo SJ. Genetic Mutation Profiles in Korean Patients with Inherited Retinal Diseases. J Korean Med Sci. 2019 Jun

7. Kim MS, Hong HK, Park KH, Woo SJ. Intravitreal Dexamethasone Implant with Plasma Autoantibody Monitoring for Cancer-Associated Retinopathy. Korean J Ophthalmol. 2019 Jun; 33(3): 298-300.

8. Kim MS, Hong HK, Ko YJ, Park KH, Ueno S, Okado S, Woo SJ, Joo K. A case of melanoma-associated retinopathy with autoantibodies against TRPM1. Doc Ophthalmol . 2020 May 29.

9. Kim MS, Park SJ, Joo K, Kang HG, Kim M, Woo SJ. Single-Haptic Dislocation of Retropupillary Iris-Claw Intraocular Lens: Outcomes of Reenclavation. Ophthalmic Surg Lasers Imaging Retina . 2020 Jul 1;51(7):384-390.

10. Kim MS, Ryoo NK, Park KH. Laser and Anti-Vascular Endothelial Growth Factor Treatment for Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration. Scientific Reports. 2020 Sep 1;10(1):14370

11. Kim MS, Cho JH, Byun SJ, Oh CM, Park KH, Park SJ. Increased Risk of Cancer in Patients with Retinal Vein Occlusion: A 12-year Nationwide Cohort Study. British Journal of Ophthalmology. 2020-316947

12. Kim MS, Woo SJ, Park KH. Phacovitrectomy versus lens-sparing vitrectomy for rhegmatogenous retinal detachment repair according to the surgical experience. RETINA. (2021 Aug 1;41(8):1597-1604)

13. Kim MS, Choi J, Lee HD, Woo SJ. Dexamethasone intravitreal implant for the treatment of macular edema following retinal vein occlusion: post hoc analysis of post-marketing surveillance data in the real-world setting in Korea. Clinical ophthalmology. 2021 Aug 27;15:3623-3636

14. Kim MS, Hwang JM, Woo SJ. Long-Term Development and Progression of Peripapillary Hyper-reflective Ovoid Mass-like Structures: Two Case Reports. Journal of neuroophthalmology. 2021 Sep 30.

¹®¼ö¿µ ¿øÀå

ÀÇÇйڻç / ¾È°úÀü¹®ÀÇ / Àü¾ÈºÎÀü¹®ÀÇ

¡¤ ¼­¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ÀÇÇйڻç
¡¤ ¼­¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç Àü¾ÈºÎ Àü¹®ÀÇ
¡¤ ¼­¿ï¾Æ»êº´¿ø ¾È°ú ÀÓ»ó °­»ç
¡¤ ÇѸ²´ëÇб³º´¿ø ¾È°úÀü°øÀÇ

¼Ò¼ÓÇÐȸ

¡¤ ´ëÇѾȰúÇÐȸ Á¤È¸¿ø
¡¤ Çѱ¹ °Ç¼º¾È ÇÐȸ Á¤È¸¿ø
¡¤ Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ(KSCRS) Á¤È¸¿ø
¡¤ ¹Ì±¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ(ASCRS) Á¤È¸¿ø
¡¤ Çѱ¹ÄÜÅÃÆ®·»ÁîÇÐȸ Á¤È¸¿ø
¡¤ ´ëÇѰ˾ÈÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹¾È°úÇÐȸ(AAO) Á¤È¸¿ø
¡¤ ¹Ì±¹½Ã°úÇÐÇÐȸ(ARVO) Á¤È¸¿ø
¡¤ Çѱ¹¿Ü¾ÈºÎÇÐȸ Á¤È¸¿ø

ÁÖ¿äÇÐȸȰµ¿

¡¤ 2015 AAO(¹Ì±¹¾È°úÇÐȸ) in Las Vegas
¡¤ 2016 AAO(¹Ì±¹¾È°úÇÐȸ) in Chicago
¡¤ 2016 ´ëÇоȰúÇÐȸ Ãß°è ¸Á¸· ±¸¿¬
¡¤ 2018 ´ëÇѾȰúÇÐȸ Ãá°è ¸Á¸· ±¸¿¬ ¹× Æ÷½ºÅÍ ¹ßÇ¥
¡¤ 2020 ´ëÇѾȰúÇÐȸ Ãß°è ¿Ü¾ÈºÎ ¹× ¹é³»Àå ±¼Àý ¼ö¼ú ±¸¿¬
¡¤ 2021 ´ëÇѾȰúÇÐȸ Ãá°è ¹é³»Àå ±¼Àý ¼ö¼ú ¿ì¼ö ±¸¿¬
¡¤ 2021 ASCRS(¹Ì±¹ ¹é³»Àå ±¼Àý¼ö¼úÇÐȸ) ±¸¿¬
¡¤ 2022 GSLS(±Û·Î¹ú ·»Áî ½ÉÆ÷Áö¾ö) in Las Vegas Æ÷½ºÅÍ ¹ßÇ¥

¹®¾È°ú ³ë¾È ¹é³»Àå ¼¾ÅÍ

¹®¾È°úÀÇ ³ë¾È ¹é³»Àå ¼¾ÅÍ´Â ºü¸¥ ¼ö¼ú½Ã°£°ú ¾ÈÁ¤¼ºÀ» ³ôÀ̱â À§ÇØ ´ëÇк´¿ø±Þ ½Ã¼³°ú Áø´Ü ¼ö¼úÀåºñ¸¦ ¿î¿µÇϰí ÀÖ½À´Ï´Ù.
  • ¼¼°è À¯ÀÏÇÑ Áö´ÉÇü ÃÊÀ½ÆÄ·Î ÅëÁõ ÃÖ¼ÒÈ­
    ¼ö¼ú °úÁ¤ Áß ¾È¾ÐÀÌ ±Þ°ÝÈ÷ º¯ÇÏ´Â ±âÁ¸ÀÇ Àåºñµé°ú´Â ´Þ¸® ¼ö¼ú Áß ¾È¾ÐÀ» ÀÚµ¿°¨ÁöÇÏ¿© ÃÖÀûÀÇ ¾È¾ÐÀ» À¯Áö½ÃÄÑ ÁֹǷΠ¼ö¼ú Áß ÅëÁõÀÌ °ÅÀÇ ¾ø½À´Ï´Ù.

  • ºü¸¥ ½Ã·Âȸº¹
    ¹é³»Àå ÈíÀÔ°ú Á¦°ÅÇÏ´Â ÀåÄ¡¸¦ ÃÖÀûÈ­ÇÏ¿© Àý°³Ã¢ ºÎÀ§ÀÇ ¿­¼Õ»ó°ú °¢¸· ºÎÁ¾ÀÌ Àû¾î ºü¸¥ ½Ã·Âȸº¹À» ±â´ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ¾ÈÀü¼ºÀ» ±Ø´ëÈ­
    ¼ö¼ú ¿ë¾àÀÌ Á÷Á¢ ±â°è¿Í ´êÁö ¾Ê´Â ºñħÅõ¼º ¹æ½ÄÀ¸·Î ¸Å ¼ö¼ú½Ã 1ȸ¿ë ÆÑ°ú 1ȸ¿ë ¿ë¾×À» »ç¿ëÇϹǷΠ°¨¿°°ú ºÎÀÛ¿ë¿¡ ´ëÇÑ ¾ÈÀü¼ºÀÌ ±Ø´ëÈ­ µÇ¾ú½À´Ï´Ù.

Àåºñ¼Ò°³

  • IOL Master 700
    ¹é³»Àå ¼ö¼úÀ̳ª ICL¼ö¼ú ½Ã ¾È±¸ ±æÀ̸¦ ÃøÁ¤ÇÏ´Â Àåºñ
    ¡¤¹é³»Àå ¼ö¼ú ½Ã »ðÀԵǴ Àΰø¼öÁ¤Ã¼ÀÇ µµ¼ö °áÁ¤, ¼ö¼úÀÌ ¾Æ¹«¸® ÀߵǾ ¼úÀü °Ë»çÇÑ µµ¼ö ÃøÁ¤ÀÌ À߸øµÇ´Â °æ¿ì ¼úÈÄ ½Ã·ÂÀúÇÏÀÇ °¡Àå Å« ¿øÀÎ
    ¡¤ÇöÀç ¼­¿ï¼º¸ðº´¿ø, ¾Æ»êº´¿ø¿¡¸¸ ÀÖ´Â ÃÖ°í°¡ ¹é³»Àå ¼úÀü °Ë»ç Àåºñ
    ¡¤¼­¿ï´ëÇб³º´¿ø µµÀÔ ÁغñÁß
    ¡¤2018³â 4¿ù ÇöÀç ·ÎÄà ¾È°ú º´¿ø ÃÖÃÊ µµÀÔ

  • OPMI Lumera 700(·ç¸Þ¶ó700)
    ´ëÇк´¿ø±Þ ¹Ì¼¼¼ö¼ú Çö¹Ì°æ

  • ¼¾Ã߸®¿Â
    ¼¼°è ÃÖÃÊ ÀÎÅÚ¸®ÀüÆ® ÇÁ¸®¹Ì¾ö ¹é³»Àå¼ö¼ú Àåºñ

  • ±¤°¢ ¾ÈÀú Ä«¸Þ¶ó
    »êµ¿ ¾øÀÌ 200µµ ¹üÀ§ÀÇ ¸Á¸· ´ëºÎºÐÀ» ÃÔ¿µÇÏ¿© ÁÖº¯ºÎ ¸Á¸· ¿­°ø, ¸Á¸· ¹Ú¸®, ´ç´¢¸Á¸·º´ÁõÀÇ Á¶±â Áø´ÜÀÌ °¡´ÉÇÕ´Ï´Ù.

Æò»ý°ü¸®½Ã½ºÅÛ

¹®¾È°ú´Â Áø·á¿Í ¼ö¼úÀ» ¹ÞÀ¸½Å ºÐµéÀÇ ´«°Ç°­À» ÁöÄѵ帮±âÀ§ÇØ ´Ù¾çÇÑ ÇÁ·Î±×·¥À» Á¦°øÇÏ¿© µå¸³´Ï´Ù.
µðÁöÅÐ Â÷Æ® ¼­ºñ½º ȨÆäÀÌÁö ȸ¿ø ¸Þ´º¸¦ ÅëÇØ °Ë»ç ¹× Áø·á±â·ÏÀ» È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.
1:1ÀÇ·áÁø Ã¥ÀÓÁø·á Á¦µµ ¼ö¼úÀ» ÁýµµÇÑ ÀÇ·áÁøÀÌ Á÷Á¢ ȯÀÚÀÇ ´« °Ç°­À» È®ÀÎÇÏ°í º¸ÁõÇÕ´Ï´Ù.
¼ö¼ú ÈÄ ÄÉ¾î ¼­ºñ½º ¿ø³» °í°´°ü¸®ÆÀÀÌ ¼ö¼ú ÈÄ ÇØÇÇÄÝ ¹× ´ÙÀ½ ³»¿ø ¿¹¾à ¾È³»¸¦ µ½°í ÀÖ½À´Ï´Ù.
Á¤±â °ËÁø Á¦µµ Á¤±âÀûÀÎ °ËÁø ÇÁ·Î±×·¥À¸·Î ´Ù¾çÇÑ ¾ÈÁúȯÀ» Á¶±â¹ß°ß, Á¶±âÄ¡·áÇÕ´Ï´Ù.